IV Artesunate

Artesunate is a derivative of the sweet wormwood plant, and was first used as a treatment for malaria. In the years since, research has shown that artesunate has an anti-cancer mechanism as well. It is one of the most powerful natural anti-cancer treatments available today.

Artesunate as an Anti-Cancer Agent

Research has shown us that cancer cells preferentially take up iron, resulting in the formation of free radicals, which then helps them mutate and grow faster. When artesunate is administered, and cancer cells absorb it, a reaction occurs inside the cells which cause them to undergo programmed cell death (apoptosis). We also have research showing that cancer cells do not develop resistance to artesunate, even when those same cells do develop resistance to chemotherapy.

Clinical Studies on Artesunate

In human studies, artesunate has shown to have a significant effect in terms of treatment outcome as well as quality of life. A recent clinical study examined intravenous artesunate in detail. One group of stage IV breast cancer patients was given intravenous artesunate alone, while another group of stage IV breast cancer patients received intravenous artesunate in combination with intravenous vitamin C. The group receiving only IV artesunate had a 74% survival rate after one year, but the group receiving IV artesunate as well as IV vitamin C had a 90% survival rate. At the 2 year mark, those receiving both treatments still had a 90% survival rate. No notable adverse effects were noted in the study.

In our practice, we incorporate IV artesunate into most of our protocols. We have found it to be both safe and effective.